Ling‐Wei Hii

2.0k total citations · 1 hit paper
31 papers, 1.4k citations indexed

About

Ling‐Wei Hii is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Ling‐Wei Hii has authored 31 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 11 papers in Oncology and 4 papers in Organic Chemistry. Recurrent topics in Ling‐Wei Hii's work include Histone Deacetylase Inhibitors Research (4 papers), Epigenetics and DNA Methylation (4 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Ling‐Wei Hii is often cited by papers focused on Histone Deacetylase Inhibitors Research (4 papers), Epigenetics and DNA Methylation (4 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Ling‐Wei Hii collaborates with scholars based in Malaysia, China and France. Ling‐Wei Hii's co-authors include Chee‐Onn Leong, Wei‐Meng Lim, Shew Fung Wong, Chin-King Looi, Chun‐Wai Mai, Maxine Swee‐Li Yee, Yih-Yih Kok, Chiew-Yen Wong, Felicia Fei‐Lei Chung and Boon Shing Tan and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Ling‐Wei Hii

31 papers receiving 1.4k citations

Hit Papers

Impact of Microplastics and Nanoplastics on Human Health 2021 2026 2022 2024 2021 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Impact of Microplastics and Nanoplastics on Human Health
    2021 628 citations Maxine Swee‐Li Yee, Ling‐Wei Hii et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ling‐Wei Hii Malaysia 17 548 547 324 230 179 31 1.4k
Yanmei Wu China 15 506 0.9× 255 0.5× 218 0.7× 100 0.4× 126 0.7× 46 1.1k
Elizabeth V. Wattenberg United States 23 876 1.6× 761 1.4× 688 2.1× 190 0.8× 137 0.8× 40 2.1k
Yuxin Yang China 20 800 1.5× 785 1.4× 590 1.8× 131 0.6× 180 1.0× 76 2.1k
Zifan Lu China 15 268 0.5× 484 0.9× 165 0.5× 150 0.7× 92 0.5× 23 1.1k
Sheng Yang China 22 347 0.6× 569 1.0× 151 0.5× 139 0.6× 223 1.2× 66 1.3k
Christoffel P. S. Badenhorst Germany 22 431 0.8× 999 1.8× 166 0.5× 84 0.4× 240 1.3× 44 1.8k
Jiufei Duan China 15 420 0.8× 237 0.4× 147 0.5× 78 0.3× 174 1.0× 18 1.1k
Lianshuang Zhang China 20 909 1.7× 341 0.6× 396 1.2× 61 0.3× 293 1.6× 41 1.8k
Hui He China 20 249 0.5× 526 1.0× 186 0.6× 155 0.7× 35 0.2× 60 1.3k
Ji Won Kim South Korea 23 213 0.4× 626 1.1× 103 0.3× 150 0.7× 126 0.7× 66 1.5k

Countries citing papers authored by Ling‐Wei Hii

Since Specialization
Citations

This map shows the geographic impact of Ling‐Wei Hii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling‐Wei Hii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling‐Wei Hii more than expected).

Fields of papers citing papers by Ling‐Wei Hii

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling‐Wei Hii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling‐Wei Hii. The network helps show where Ling‐Wei Hii may publish in the future.

Co-authorship network of co-authors of Ling‐Wei Hii

This figure shows the co-authorship network connecting the top 25 collaborators of Ling‐Wei Hii. A scholar is included among the top collaborators of Ling‐Wei Hii based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling‐Wei Hii. Ling‐Wei Hii is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hii, Ling‐Wei, et al.. (2024). Polyethylene glycol-phospholipid functionalized single-walled carbon nanotubes for enhanced siRNA systemic delivery. Scientific Reports. 14(1). 30098–30098. 3 indexed citations
2.
Peter, Elizabeth, et al.. (2024). Epigenetic Drug Interventions in Breast Cancer: A Narrative Review of Current Research and Future Directions. SHILAP Revista de lepidopterología. 7(1). 4 indexed citations
3.
4.
Mai, Chun‐Wai, Felicia Fei‐Lei Chung, Alan Soo Beng Khoo, et al.. (2022). Functional Roles of JNK and p38 MAPK Signaling in Nasopharyngeal Carcinoma. International Journal of Molecular Sciences. 23(3). 1108–1108. 106 indexed citations
5.
Lim, Wei‐Meng, et al.. (2022). Targeting pancreatic cancer immune evasion by inhibiting histone deacetylases. World Journal of Gastroenterology. 28(18). 1934–1945. 17 indexed citations
6.
Mai, Chun‐Wai, Mohd Zulkefeli, Thiagarajan Madheswaran, et al.. (2022). Novel Gemcitabine-Re(I) Bisquinolinyl Complex Combinations and Formulations With Liquid Crystalline Nanoparticles for Pancreatic Cancer Photodynamic Therapy. Frontiers in Pharmacology. 13. 903210–903210. 8 indexed citations
7.
8.
Hii, Ling‐Wei, Chun‐Wai Mai, Chee‐Onn Leong, et al.. (2021). Unusual diarylheptanoid-phenylpropanoid adducts and diarylheptanoid alkaloids from Pellacalyx saccardianus. Phytochemistry Letters. 46. 36–44. 2 indexed citations
9.
Looi, Chin-King, Ling‐Wei Hii, Felicia Fei‐Lei Chung, et al.. (2021). Roles of Inflammasomes in Epstein–Barr Virus-Associated Nasopharyngeal Cancer. Cancers. 13(8). 1786–1786. 20 indexed citations
10.
Hii, Ling‐Wei, et al.. (2021). Gene expression profiling of giant fibroadenomas of the breast. Surgical Oncology. 37. 101536–101536. 3 indexed citations
11.
Hii, Ling‐Wei, Felicia Fei‐Lei Chung, Chun‐Wai Mai, et al.. (2020). Sphingosine Kinase 1 Regulates the Survival of Breast Cancer Stem Cells and Non-stem Breast Cancer Cells by Suppression of STAT1. Cells. 9(4). 886–886. 32 indexed citations
12.
Looi, Chin-King, Ling‐Wei Hii, Siew Ching Ngai, Chee‐Onn Leong, & Chun‐Wai Mai. (2020). The Role of Ras-Associated Protein 1 (Rap1) in Cancer: Bad Actor or Good Player?. Biomedicines. 8(9). 334–334. 54 indexed citations
13.
Hii, Ling‐Wei, et al.. (2020). Molecular Mechanisms and Potential Therapeutic Reversal of Pancreatic Cancer-Induced Immune Evasion. Cancers. 12(7). 1872–1872. 23 indexed citations
14.
Hii, Ling‐Wei, Swee‐Hua Erin Lim, Chee‐Onn Leong, et al.. (2019). The synergism of Clinacanthus nutans Lindau extracts with gemcitabine: downregulation of anti-apoptotic markers in squamous pancreatic ductal adenocarcinoma. BMC Complementary and Alternative Medicine. 19(1). 257–257. 24 indexed citations
15.
Hii, Ling‐Wei, et al.. (2019). Histone deacetylase (HDAC) inhibitors and doxorubicin combinations target both breast cancer stem cells and non-stem breast cancer cells simultaneously. Breast Cancer Research and Treatment. 179(3). 615–629. 29 indexed citations
16.
17.
Chung, Felicia Fei‐Lei, Kuan‐Hon Lim, Tracey D. Bradshaw, et al.. (2017). Cudraflavone C Induces Tumor-Specific Apoptosis in Colorectal Cancer Cells through Inhibition of the Phosphoinositide 3-Kinase (PI3K)-AKT Pathway. PLoS ONE. 12(1). e0170551–e0170551. 63 indexed citations
18.
Chung, Felicia Fei‐Lei, Vijay J. Raja, Boon Shing Tan, et al.. (2017). Jerantinine A induces tumor-specific cell death through modulation of splicing factor 3b subunit 1 (SF3B1). Scientific Reports. 7(1). 42504–42504. 47 indexed citations
19.
Tan, Boon Shing, Kai Hung Tiong, Heng Lungh Choo, et al.. (2015). Mutant p53-R273H mediates cancer cell survival and anoikis resistance through AKT-dependent suppression of BCL2-modifying factor (BMF). Cell Death and Disease. 6(7). e1826–e1826. 89 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yanmei Wu Breakdown of academic impact, for papers by Elizabeth V. Wattenberg Breakdown of academic impact, for papers by Yuxin Yang Breakdown of academic impact, for papers by Zifan Lu Breakdown of academic impact, for papers by Sheng Yang Breakdown of academic impact, for papers by Christoffel P. S. Badenhorst Breakdown of academic impact, for papers by Jiufei Duan Breakdown of academic impact, for papers by Lianshuang Zhang Breakdown of academic impact, for papers by Hui He Breakdown of academic impact, for papers by Ji Won Kim
Rankless by CCL
2026